OCULAR THERAPEUTIX, INC (OCUL) › Operating IncomeOCULAR THERAPEUTIX, INC (OCUL) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2012: -$13.67M2013: -$12.90M2014: -$27.09M2015: -$38.20M2016: -$43.33M2017: -$61.92M2018: -$59.12M2019: -$85.80M2020: -$62.85M2021: -$78.04M2022: -$78.65M2023: -$82.38M2024: -$171.78M2025: -$270.02M-$270.02M2012Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$270.02M-57.2%2024-$171.78M-108.5%2023-$82.38M-4.7%2022-$78.65M-0.8%2021-$78.04M-24.2%2020-$62.85M+26.8%2019-$85.80M-45.1%2018-$59.12M+4.5%2017-$61.92M-42.9%2016-$43.33M-13.4%2015-$38.20M-41.0%2014-$27.09M-110.0%2013-$12.90M+5.6%2012-$13.67M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share